V029-5281 Screening compound: 2-(4-chlorophenoxy)-N-{1-[3-(4-methylphenyl)-1,2,4-oxadiazol-5-yl]-2-phenylethyl}acetamide

V029-5281 Screening compound: 2-(4-chlorophenoxy)-N-{1-[3-(4-methylphenyl)-1,2,4-oxadiazol-5-yl]-2-phenylethyl}acetamide
V029-5281 Screening compound: 2-(4-chlorophenoxy)-N-{1-[3-(4-methylphenyl)-1,2,4-oxadiazol-5-yl]-2-phenylethyl}acetamide alternative view

Chemical Structure Depiction of ChemDiv screening compound V029-5281
2-(4-chlorophenoxy)-N-{1-[3-(4-methylphenyl)-1,2,4-oxadiazol-5-yl]-2-phenylethyl}acetamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

V029-5281

Molecular Formula

C25H22ClN3O3 (C25 H22 ClN3 O3)

Compound Name

2-(4-chlorophenoxy)-N-{1-[3-(4-methylphenyl)-1,2,4-oxadiazol-5-yl]-2-phenylethyl}acetamide

IUPAC name

2-(4-chlorophenoxy)-N-{1-[3-(4-methylphenyl)-124-oxadiazol-5-yl]-2-phenylethyl}acetamide

SMILES

Cc(cc1)ccc1-c1noc(C(Cc2ccccc2)NC(COc(cc2)ccc2Cl)=O)n1

InChI

InChI=1S/C25H22ClN3O3/c1-17-7-9-19(10-8-17)24-28-25(32-29-24)22(15-18-5-3-2-4-6-18)27-23(30)16-31-21-13-11-20(26)12-14-21/h2-14,22H,15-16H2,1H3,(H,27,30)/t22-/m0/s1

InChI Key

LNHUIDAHTBDWJL-QFIPXVFZSA-N

MDL Number (MFCD)

MFCD19780283

Chemical and Physical Properties

Saltdata

not_available

Molecular Weight

447.92

Hydrogen Bond Acceptors Count

6.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

9.00

Number of Nitrogen and Oxygen Atoms

6

Partition Coefficient, logP

6.182

Distribution Coefficient, logD

6.182

Water Solubility, LogSw

-6.20

Polar Surface Area

62.974

Acid Dissociation Constant (pKa)

12.48

Base Dissociation Constant (pKb)

-3.99

Number of Chiral Centers

1.00

Percent sp3 carbon bonding

16.00

V029-5281 in Drug Discovery

Included in Screening Libraries

Akt-Targeted Library (14764 compounds)

Anti-HIV1 Library (19540 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Digestive system
  • Respiratory tract
  • Male
  • Female
  • Hemic and lymphatic
  • Skin
  • Antiviral
  • Infections
  • Immune system
Targets:
  • Kinases

References: we are preparing a list of scientific research reports with V029-5281 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound V029-5281?
Check Price and Availability of V029-5281, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of V029-5281 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for V029-5281
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for V029-5281
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of V029-5281 available by request